Picture of BB Biotech AG logo

BION BB Biotech AG Share Price

0.000.00%
ch flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-5.2%
3m+7.88%
6m-1.96%
1yr-22.48%
Volume Change (%)
10d/3m-2.64%
Price vs... (%)
52w High-7.1%
50d MA+1.12%
200d MA+11.51%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)22.88
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)5.62%
Valuation (ttm)IndustryMarket
Price to Book Value1.11
Price to Tang. Book1.11
Price to Free Cashflow11.83
Price to Sales4,874.05
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-8.89%
Return on Equity-8.25%
Operating Margin-38967.55%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of BB Biotech AG EPS forecast chart

Profile Summary

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
November 10th, 1993
Public Since
November 8th, 2006
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
ch flag iconSIX Swiss Exchange
Shares in Issue
54,846,000

BION Share Price Performance

Upcoming Events for BION

Q1 2024 BB Biotech AG Earnings Release

Q2 2024 BB Biotech AG Earnings Release

Similar to BION

Picture of Addex Therapeutics logo

Addex Therapeutics

ch flag iconSIX Swiss Exchange

Picture of BACHEM HOLDING AG logo

BACHEM HOLDING AG

ch flag iconSIX Swiss Exchange

Picture of Idorsia logo

Idorsia

ch flag iconSIX Swiss Exchange

FAQ